United Therapeutics | UTHR - Pre Tax Profit

Stock Price
485.36
Daily Change
6.43 1.34%
Monthly
-3.64%
Yearly
39.59%
Q1 Forecast
455.03

United Therapeutics reported $438M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Amarin USD -8.12M 5.34M Sep/2025
Ardelyx USD -867K 18.21M Sep/2025
Baxter International USD 121M 12M Sep/2025
Bayer EUR -1.16B 735M Sep/2025
Biogen USD 557.3M 186.7M Sep/2025
BioMarin Pharmaceutical USD -26.32M 324.19M Sep/2025
Gilead Sciences USD 2.43B 780M Jun/2025
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
Halozyme Therapeutics USD 218.96M 14.02M Sep/2025
Insmed USD -368.7M 48.26M Sep/2025
Ionis Pharmaceuticals USD -129M 253M Sep/2025
J&J USD 4.97B 2.53B Dec/2025
Moderna USD -187M 631M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
PTC Therapeutics USD -23.07M 47.98M Sep/2025
Regeneron Pharmaceuticals USD 1.76B 244.6M Sep/2025
Sarepta Therapeutics USD -194.05M 347.69M Sep/2025
Teva Pharmaceutical Industries USD 91M 555M Dec/2025
United Therapeutics USD 438M 29.6M Sep/2025
Vertex Pharmaceuticals USD 1.3B 15.8M Sep/2025